PATENT CLAIM ANALYSIS

Application Number: 15776913
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "165000"]

Abstract:
The present invention relates to a pharmaceutical composition containing a poorly soluble drug, hyaluronic acid, and a fatty acid, and to a method for preparing the same. The pharmaceutical composition of the present application has excellent stability even for long-term storage and allows a sustained release of the drug, thereby preventing an overdose of the drug and improving the therapeutic efficiency at an effected area.

Claim (Index 6):
The pharmaceutical composition of  claim 3 , wherein the fatty sulfonic acid or a salt thereof is one or more selected from the group consisting of myristoleyl methane sulfate, sodium palmityl sulfate, sodium oleyl sulfate, sodium elaidyl sulfate, elaidyl methane sulfate, vaccenyl methane sulfate, linoleyl methane sulfate, linoelaidyl methane sulfate, arachidyl sulfate sodium, erucyl methane sulfate, docosahexaenoyl methane sulfate, sodium capryl sulfate, sodium lauryl sulfate, sodium myristyl sulfate, sodium palmityl sulfate, sodium stearyl sulfate, sodium arachidyl sulfate, and sodium behenyl sulfate.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 93.0
- Lexical Diversity: 1.61364
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13326477', '10511707', '10571005', '13825552', '12746754']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.762817164950371
- 35 USC 102 Novelty (BERT): 0.5012054636834287
- Combined Prediction Score: 0.7366559948236767
- Mean Citation Score: 202.93644
- Max Citation Score: 209.82545
- Similarity Product: 140.88976615915

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test